SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Kala Pharmaceuticals On March 10, Notified Jefferies It Was Suspending,Terminating Prospectus Related To Sales Agreement Entered Into On Aug 9, 2018; Will Not Make Any Sales Of Common Stock Pursuant To Sales Agreement Unless A New Prospectus Is Filed

-Reuters

Reuters · 03/11/2020 10:21